2009 ICT Conference

Info Centre Home | Contents | Search | eMJA Home


Short course
6.4
Benzodiazepines
Commonly used benzodiazepines, half-lives, age effects and indications for use
Range of daily doses (mg)
Elimination
half-life (hours)
DrugUsual indicationYoung, healthyElderlyEffects of increasing age

Long elimination half-life
ClobazamAnxiety, panic attacks*30-8010-2012-60Elimination half-life decreased
DiazepamAnxiety, panic attacks*6-802-4020-90Elimination half-life increased
FlurazepamInsomnia15-6015-3040-100Toxicity increased
Intermediate elimination half-life
AlprazolamAnxiety, panic attacks*1-40.25-16-20Elimination half-life decreased
FlunitrazepamInsomnia0.5-20.5-220-30Little effect
LorazepamAnxiety2-42-410-20Little effect
NitrazepamInsomnia5-205-1020-30Elimination half-life increased
OxazepamAnxiety45-9015-304-14No effect
TemazepamInsomnia10-3010-208-22Little effect
Short elimination half-life
TriazolamInsomnia0.5-20.5-15-10Elimination half-life increased

*The doses used for the control of panic attacks may need to be higher than those for other anxiety states (e.g., 6-10 mg/day of alprazolam to control panic disorder is not uncommon).
On to section 6.5 . . .

Full text article      www.mja.com.au      © 1998 MJA